Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

Share Price is delayed by 15 minutes
Get Live Data
2.00    0.00 (0.00%)
Bid:
1.90
Ask:
2.10
Spread: 0.20 (10.526%)
Market Cap: £2.74m
IGE Live PriceLast checked at - London Stock Exchange

Intraday Image Scan Holdings Share Chart

Trading Update

4 Nov 2025 07:00

RNS Number : 9856F
Image Scan Holdings PLC
04 November 2025
 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

IMAGE SCAN HOLDINGS PLC

("Image Scan" or the "Company")

Trading Update

Profitable second half, Cash Position Enhanced and Improved Order Book

Image Scan Holdings PLC ("Image Scan" or the "Company"), the specialist provider of X-ray screening systems, today announced its pre-close trading update for the year ended 30 September 2025 ("FY25").

The financial results for the full year were impacted by a slow start to the year and compounded by supply chain constraints and delays to a high-value contract. Pleasingly, as anticipated in the interim report, trading in the second half was profitable and demonstrates a considerable operational turnaround.

Financial Highlights (Unaudited)

Subject to audit, the Group expects to report the following key financial metrics for FY25:

· Revenue of approximately £1.6 m (FY24: £2.9 m).

· An unaudited pre-tax loss of £0.3 m (FY24: pre-tax profit £0.2 m).

· A robust cash position. As at 30 September 2025, the Group had cash balances of £1.1 m (FY24: £0.9 m).

Operational Highlights and Key Factors

Key factors influencing the FY25 performance include:

· H1 Slow: challenging start to the year, driven by specific timing issues and external supply issues.

· H2 Recovery: Following a significant loss in the first half of the year, the second half proved to be significantly profitable. This substantial operational rebound mitigated the overall full-year loss

· Cost Discipline: The full-year loss was restricted due to the rigorous cost management.

· Contract Uncertainty: Delivery capacity was impacted by component supplies and long lead times, which was previously notified in the trading update on 21 August 2025.

· Major Contract Delay: The financial performance was materially affected by the slow progression of the previously announced major defence contract into realisation.

· Order Book and Forward Visibility

The Group's forward visibility remains strong, underpinned by a robust order book:

· As at 30 September 2025, the order book stood at £4.7 m (FY24: £4.5 m), which is expected to be delivered primarily in FY26 and FY27.

· This growing forward order book confirms the strong intrinsic market demand for Image Scan's high-performance solutions to the security and defence sectors, aided by industrial sector revenues particularly for support services.

Looking Ahead

Image Scan remains focused on expanding its product range, strengthening its market position, and accelerating the conversion of the substantial order book. The Group is encouraged by activity levels post year-end and what appears to be a much more buoyant market environment.

The strong financial position provides the Company with the financial resilience and flexibility to pursue strategic growth.

Vincent Deery, Chief Executive of Image Scan, commented:

"We acknowledge that the timing challenges inherent in complex government procurement programmes, coupled with the supply chain difficulties that led to market guidance being withdrawn in August, have resulted in disappointing results for the year ended 30 September 2025."

"However, I am extremely encouraged by the operational recovery achieved. Following the significant loss recorded in H1, the second half of the year proved to be significantly profitable, which mitigated the full-year loss. The operational stabilisation is a testament to rigorous and sustained cost management."

"Crucially, we strengthened our closing cash position to £1.1m, demonstrating sound financial discipline in a difficult trading year. The robust £4.7m forward order book confirms the underlying and growing market demand for our high-performance security and defence solutions, providing excellent revenue visibility into FY26 and beyond. Furthermore, we are encouraged by activity levels post year-end and what appears to be a much more buoyant market environment."

"Our immediate focus is on accelerating the conversion and realisation of this substantial pipeline, including the delayed defence programme. Building on this strong foundation and enhanced liquidity, we remain focused on our product development and continue to evaluate strategic opportunities to accelerate our growth trajectory."

For further information on the Company, please visit: www.ish.co.uk and for further information on its products, please visit: www.3dx-ray.com

 

-ENDS-

 

Image Scan Holdings plc Tel: +44 (0) 1509 817400

Vincent Deery CEO

Sarah Atwell-King, CFO & Company Secretary

 

 

Zeus - Nominated Advisor and Corporate Broker Tel: +44 (0)203 829 5000

Mike Coe/James Bavister (Investment Banking)

 

ABOUT IMAGE SCAN HOLDINGS PLC

About Image Scan Holdings plc

The core activity of the Group is the manufacture of portable X-ray systems for security and counter terrorism applications. The Group recently launched a cabinet X-ray machine and is replacing its Axis range of checkpoint X-ray systems with new machines developed with a partner. All these products are taken to market across the world through a strong network of international partners.

 

In addition, over the last seventeen years, Image Scan has developed and manufactured industrial X-ray inspection systems, the MDXi range. The primary market for these systems is in automotive emissions control where they are used for quality control inspection of catalytic converters and diesel particulate filters.

 

The visibility and reach of the Company's 3DX-Ray brand has been further strengthened through a new LinkedIn profile focussed on its EOD and counter-terrorism activities. This can be found at: https://www.linkedin.com/company/3dx-ray/

 

For further information on the Company, please visit: www.ish.co.uk - and for further information on its products, please visit: www.3dx-ray.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFSEFMDEISEDF
Date   Source Headline
18th Jan 20238:52 amRNSPosting of annual report and notice of AGM
17th Jan 20233:23 pmRNSImage Scan makes first sale of new product
23rd Dec 202211:54 amRNSDirector/PDMR Shareholding
14th Dec 20224:14 pmRNSAppointment of Director
13th Dec 20224:25 pmRNSHolding(s) in Company
13th Dec 20227:00 amRNSFinal Results
9th Dec 20227:00 amRNSNotice of Results
6th Oct 20227:00 amRNSTrading Update
1st Aug 20224:10 pmRNSHolding(s) in Company
25th May 20227:00 amRNSBoard Changes
27th Apr 20227:00 amRNSInterim Results
3rd Mar 20227:00 amRNSNew Industrial Customer
22nd Feb 20223:03 pmRNSResult of AGM
22nd Feb 20227:00 amRNSTrading Statement
20th Jan 202211:53 amRNSPosting of Accounts & AGM Notice
12th Jan 20227:00 amRNSLaunch of new portable X-ray system
10th Dec 20219:05 amRNSInvestor Presentation
7th Dec 202110:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
7th Dec 20217:00 amRNSFinal Results
10th Nov 20211:16 pmRNSAppointed global distributor for Serstech AB
10th Nov 20217:00 amRNSPortable x-ray sale to US Federal Agency
3rd Nov 20217:00 amRNSPre-Close Trading Update
27th Oct 20219:32 amRNSDirector Declaration
13th Sep 20217:00 amRNSTrading Update – New Orders
17th Jun 20217:00 amRNSFirst portable X-Ray sale to Australia
28th Apr 202110:03 amRNSInterim Report - Replacement
28th Apr 20217:00 amRNSNew order
28th Apr 20217:00 amRNSInterim Report
23rd Feb 202111:18 amRNSResult of AGM
22nd Feb 20217:00 amRNSTrading Statement
15th Feb 202111:33 amRNSMello presentation
21st Jan 20217:00 amRNSContract win
6th Jan 20217:00 amRNSPosting of Annual Report and Notice of AGM
4th Dec 20207:00 amRNSFinal Results
28th Oct 20207:00 amRNSTrading Update
12th Oct 20207:00 amRNSLaunch of innovative new security system
1st Sep 20207:00 amRNSTrading Update
13th Jul 20207:00 amRNSPartnership Agreement
15th Jun 202012:05 pmRNSHolding(s) in Company
15th Jun 20207:00 amRNSChange of Adviser
29th Apr 20207:00 amRNSInterim Results
25th Feb 20203:00 pmRNSResult of AGM
6th Feb 20207:00 amRNSTrading Update
21st Jan 20207:00 amRNSPosting of Annual Report and Notice of AGM
3rd Dec 20197:00 amRNSPreliminary Results
21st Oct 20197:00 amRNSPre-Close Trading Update
18th Sep 20197:00 amRNSContract Win and Further Trading Update
26th Jun 20197:00 amRNSTrading Update
24th May 20191:35 pmRNSHolding(s) in Company
25th Apr 20197:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.